CSL222 (Adeno-associated viral vector serotype 5 [AAV5]-hFIXco-Padua)

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

CSL222 (Adeno-associated viral vector serotype 5 [AAV5]-hFIXco-Padua)
Treatment and conditionWhere it standsTrials
CSL222 (Adeno-associated viral vector serotype 5 [AAV5]-hFIXco-Padua) for hemophilia bPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1